Dr. Garcia is one of the foremost researchers world-wide in the study of neurocysticercosis, a preventable parasitic infection of the central nervous system caused by the pork tapeworm Taenia solium. His team has performed several of the most important studies examining the clinical benefits of the cysticidal drugs albendazole and praziquantel, improving treatment and preventing the need for retreatment of patients with neurocysticercosis. Dr. Garcia has a long history in global health research and training, including the successful direction of a 10 year cysticercosis elimination program in northern coastal Peru funded by the Bill & Melinda Gates Foundation. He leads the Cysticercosis Working Group in Peru, a multi-institutional group working in varied aspects of cysticercosis research supported by NIH, The Wellcome Trust, and other agencies. This network also offers hands-on training in global health research to local scientists and health professionals, supported by the NIH Fogarty International Center. His lab has over 250 peer-reviewed publications in cysticercosis and other research in diverse subjects of public health importance in Peru.